US2006189541A1PendingUtilityA1

Methods of treating dry eye disorders

50
Assignee: GAMACHE DANIEL APriority: Sep 20, 2002Filed: Mar 28, 2006Published: Aug 24, 2006
Est. expirySep 20, 2022(expired)· nominal 20-yr term from priority
A61P 43/00A61K 31/416A61P 27/02A61K 31/616A61K 31/505A61K 31/506A61K 31/551A61K 31/192A61K 38/08
50
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Inhibitors of cytokine synthesis in nonimmune, resident ocular surface cells are useful for treating dry eye disorders and other disorders requiring the wetting of the eye.

Claims

exact text as granted — not AI-modified
1 - 7 . (canceled)  
   
   
       8 . A method for the treatment of dry eye which comprises administering to a mammal a composition comprising a pharmaceutically acceptable carrier and a pharmaceutically effective amount of a c-jun N-terminal kinase inhibitor.  
   
   
       9 . The method of  claim 8  wherein the pharmaceutically effective amount of the c-jun N-terminal kinase inhibitor is 0.001-1.0% (w/w).  
   
   
       10 . The method of  claim 8  wherein the composition is topically administered to the eye.  
   
   
       11 . The method of  claim 8  wherein the dry eye is associated with refractive surgery.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.